Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-092419
Filing Date
2025-07-01
Accepted
2025-07-01 20:23:36
Documents
2
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1611
2 EX-24 kytx-ex24.htm EX-24 13848
  Complete submission text file 0000950170-25-092419.txt   16940
Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address
GRASSO MARC (Reporting) CIK: 0001748894 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41947 | Film No.: 251098065

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Issuer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)